Fundraising Fox

Scopus BioPharma

New York, US · Founded 2017 · Delaware corporation

Biotech

Founders & leadership

Scopus BioPharma was founded in 2017 by Joshua R. Lamstein.

JR
Joshua R. LamsteinCo-Chairman and Director
AP
Ashish P. SanghrajkaPresident and Director
RG
Robert GibsonVice Chairman, Secretary, Treasurer and Director
IS
Ira Scott GreenspanNamed on SEC filing

Board

PH
Paul HopperCo-Chairman and Director

Reported raises · per SEC filings

Form D private placements

$19.1M disclosed across 5 rounds · 2019–2021

▶$9.8MraisedDec 2021 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul E. HopperDirector
  • Raphael HofsteinDirector
  • Ashish P. SanghrajkaDirector
  • David S. BattlemanDirector
  • Ira Scott GreenspanExecutive Officer, Director
  • David A. BuckelDirector
  • Joshua LamsteinExecutive Officer, Director
  • Robert J. GibsonExecutive Officer, Director
  • David WeildDirector
Offering amount
$9.8M
Amount sold
$9.8M
Sales commissions
$828.8K
Placement agents
H.C. Wainwright & Co. LLC
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.3MraisedJul 2020 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ira Scott GreenspanDirector
  • Ashish P. SanghrajkaExecutive Officer, Director
  • Paul HopperExecutive Officer, Director
  • Robert J. GibsonExecutive Officer, Director
  • Joshua R. LamsteinExecutive Officer, Director
Offering amount
$6.3M
Amount sold
$6.3M
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedJul 2020 · 24 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ashish P. SanghrajkaExecutive Officer, Director
  • Paul J. HopperExecutive Officer, Director
  • Joshua R. LamsteinExecutive Officer, Director
  • Ira Scott GreenspanDirector
  • Robert GibsonExecutive Officer, Director
Offering amount
$2.3M
Amount sold
$1.9M
Sales commissions
$191.2K
Proceeds to insiders
$46.2K
Placement agents
HCFP/Capital Markets LLC
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$636.2KraisedJul 2020 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ashish P. SanghrajkaExecutive Officer, Director
  • Joshua R. LamsteinExecutive Officer, Director
  • Robert J. GibsonExecutive Officer, Director
  • Ira Scott GreenspanDirector
  • Paul HopperExecutive Officer, Director
Offering amount
$636.2K
Amount sold
$636.2K
Proceeds to insiders
$46.2K
First sale
Feb 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$450.5KraisedAug 2019 · 17 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Morris C. LasterExecutive Officer, Director
  • Joshua R. LamsteinExecutive Officer, Director
  • Robert J. GibsonExecutive Officer, Director
  • Ira Scott GreenspanDirector
Offering amount
$600K
Amount sold
$450.5K
Sales commissions
$45K
Placement agents
HCFP/Capital Markets LLC
First sale
Jul 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Scopus BioPharma Inc (SCPS)morningstar.com · May 2026

Frequently asked questions

Who founded Scopus BioPharma?
Scopus BioPharma was founded by Joshua R. Lamstein in 2017.
How much funding has Scopus BioPharma raised?
Scopus BioPharma has disclosed $19.1M raised across 5 rounds.
Where is Scopus BioPharma headquartered?
Scopus BioPharma is headquartered in New York, US.